Literature DB >> 9892860

Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers.

R Luthringer1, G Rinaudo, M Toussaint, P Bailey, G Muller, A Muzet, J Macher.   

Abstract

Apomorphine, a dopamine receptor agonist (given in a dose of 0.75 mg s.c.), was administered to 8 healthy volunteers; electroencephalograph (EEG) and event-related potential (ERP) mapping were performed before dosing and 0.5, 1.5 and 2.5 h after dosing. Apomorphine caused an overall increase in beta activity at time 0.5 h in both absolute and relative energy; P300 and CNV ERPs were not significantly altered, although a tendency towards increased P300 latency was seen. The results confirm that the EEG mapping technique is sufficiently sensitive to monitor dopaminergic neurochemical stimulation by means of apomorphine. This could lead to a new, non-invasive and repeatable method for monitoring central neuronal systems which is more convenient to apply repeatedly than for example positron emission tomography techniques. Furthermore, electrophysiological techniques undoubtedly constitute an alternative to classical neuroendocrinological methods, allowing a more direct assessment of central nervous system neurotransmission. Finally, these EEG approaches could lead to better characterization of drugs acting on dopaminergic pathways, such as antipsychotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892860     DOI: 10.1159/000026560

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  8 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

3.  Sensorimotor effects of pergolide, a dopamine agonist, in healthy subjects: a lateralized readiness potential study.

Authors:  Thomas Rammsayer; Jutta Stahl
Journal:  Psychopharmacology (Berl)       Date:  2006-05-04       Impact factor: 4.530

4.  Human models as tools in the development of psychotropic drugs.

Authors:  Christian Gilles; Thérèse Schunck; Gilles Erb; Izzie Jacques Namer; Yann Hodé; Jean-François Nedelec; Peter Boeijinga; Remy Luthringer; Jean-Paul Mâcher
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

5.  Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate.

Authors:  Anke M W Linssen; Eric F P M Vuurman; Anke Sambeth; Stephane Nave; Will Spooren; Gabriel Vargas; Luca Santarelli; Wim J Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-05-20       Impact factor: 4.530

6.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

7.  Time-resolved influences of functional DAT1 and COMT variants on visual perception and post-processing.

Authors:  Stephan Bender; Thomas Rellum; Christine Freitag; Franz Resch; Marcella Rietschel; Jens Treutlein; Christine Jennen-Steinmetz; Daniel Brandeis; Tobias Banaschewski; Manfred Laucht
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  The computational anatomy of psychosis.

Authors:  Rick A Adams; Klaas Enno Stephan; Harriet R Brown; Christopher D Frith; Karl J Friston
Journal:  Front Psychiatry       Date:  2013-05-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.